Immunoassays Move Into High-Throughput Applications and Diagnostics
A New Report From Biocompare, Inc. Finds That R&D Systems and BD Biosciences Share Top Honors as Immunoassay Suppliers in Drug Discovery and Development
SOUTH SAN FRANCISCO, CA -- (MARKET WIRE) -- January 16, 2006 -- A new report from Biocompare, Inc., 2005 Immunoassay Report, based on a survey of over 640 researchers, presents that immunoassays are used in basic research and proteomics applications, consistent with scientific research trends in general. ELISAs are the immunoassay of choice and find the top vendors strongly competing with one another in a very tight market.
The survey explores the particular immunoassays used and their suppliers, finding R&D Systems and BD Biosciences at the top of the list. The report discusses the sample types and numbers of samples analyzed and the detection methods employed, while delving into questions of multiplex systems. The survey finds that immunoassay reproducibility is the most important feature that researchers are looking for in their systems of choice.
Primary screening in drug discovery continues to fuel immunoassay development, including cell-based and high-content assays. High-throughput applications and miniaturization have created a need for multiplex systems, as most researchers find themselves trying to maximize productivity using multiwell plates. Microarray technologies are finding expanded use in the immunoassay realm as well, expecting to contribute generously to future revenue growth in molecular diagnostics specifically. The revenue stream for immunoassay development is strongest in the applied sciences, where diagnostics applications are expected to demand the expansion of assays into multiplex and higher-throughput systems.
Companies can take advantage of the shifting trends in immunoassay applications by shifting their own product development direction as well. "The loss in customer base can be reclaimed by offering innovative, emergent technologies and devising new fields of application for existing technologies to attract customers, even among cost-conscious sectors," noted the Frost & Sullivan industry analyst, Isaac Meek. New product development, especially in the area of high-throughput diagnostics, is sure to bring huge financial benefits.
This report, 2005 Immunoassay Report, available from Biocompare, Inc., explores researchers' purchasing plans and research approaches in the area of immunoassay applications. More information about this and other reports available from Biocompare can be found at: http://www.biocompare.com/research
Biocompare, Inc. (http://www.biocompare.com), headquartered in South San Francisco, California, is a global media company informing and connecting the buyers, users, and sellers of life science products. By combining an in-depth knowledge of life science products and new technologies with the power of the internet, Biocompare offers a dynamic, relevant, and innovative media-based marketplace for life science information.